The report indicates the 2018 Los Angeles luxury market continued to perform as record breaking sales hit the books. Most notably, a confidential $110 Million transaction in Malibu broke the Playboy Mansion’s previous record as the most expensive residential sale in the history of Los Angeles. Hilton & Hyland is proud to have represented the sellers of both historic transactions.
Overall, Hilton & Hyland enjoyed a massive 43% of the $20 million+ residential market in 2018, a slight increase from years past. The firm also maintained a dominant 25% market share of the $10 million+ local residential market and 21% of the $6 million+ local residential market respectively. Discretion continued to be their specialty as 39% of top transactions of the year were off-market listings, with 22 of 56 sales priced above $10 million being sold confidentially.
All of this, however, would not have been possible without an elite roster of the highest caliber agents in the world. Together, Hilton & Hyland continues to set the standard for luxury real estate marketing and branding with the launch of their newly designed website, expansion of their global audience, and interaction with its industry-leading social network.
For more information, please contact:
SOURCE Hilton & Hyland
FIORE GOLD LTD. (TSXV: F) (OTCQB: FIOGF) (“Fiore” or the “Company” – https://www.commodity-tv.com/ondemand/companies/profil/fiore-gold-ltd/) is pleased to report results from the current drilling program at its
PITTSBURGH, Nov. 24, 2020 /PRNewswire/ — The PNC Financial Services Group, Inc. (NYSE: PNC) announced today that Chairman, President and Chief Executive Officer William S. Demchak
FORT WORTH, Texas, Nov. 24, 2020 /PRNewswire/ — If TV, podcasts, and news are any indication, people remain fascinated by the past, transfixed by true crime
Results Featured in Inside GNSS Article on CAST Navigation GNSS/INS SimulatorsALHAMBRA, CA, Nov. 24, 2020 (GLOBE NEWSWIRE) — EMCORE Corporation (Nasdaq: EMKR), a leading provider
The new rules introduce a harmonised model for representative action in all member states that guarantees consumers are well protected against mass harm, while ensuring
NEW YORK, Nov, 24, 2020 /PRNewswire/ — Oramed Pharmaceuticals Inc. (Nasdaq/TASE: ORMP) (www.oramed.com), a clinical-stage pharmaceutical company focused on the development of oral drug delivery systems,